Deals with AstraZeneca, GlaxoSmithKline boost Pozen
Bizjournals.com, NC
Revenue jumped, to 66.1 million, from .4 million, as the company brought in .8 million more from the AstraZeneca agreement and .4 million in royalties from GlaxoSmithKline (NYSE: GSK) on sales of the migraine drug Treximet. …
Pozen 4Q loss narrows on partnership payments Forbes
Pozen posts narrower-than-expected Q4 loss Reuters
POZEN Reports Fourth Quarter and Year End 2008 Results MarketWatch (press release)
RTT News - Local Tech Wire
all 21 news articles